Clinical phenotype and predictors of recurrence in childhood IgA vasculitis
European Journal of Pediatrics, cilt.185, sa.11, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 185 Sayı: 11
- Basım Tarihi: 2026
- Doi Numarası: 10.1007/s00431-026-07576-0
- Dergi Adı: European Journal of Pediatrics
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE, Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest)
- Anahtar Kelimeler: Arthritis, Childhood, IgA vasculitis, Recurrence, Relapse predictors
- Ankara Yıldırım Beyazıt Üniversitesi Adresli: Evet
Özet
IgA vasculitis (IgAV) is generally considered a self-limited disease in childhood; however, recurrent episodes may occur during the disease course. The clinical phenotype and associated factors of recurrent disease remain to be clearly defined. This study aimed to evaluate the clinical characteristics of recurrent IgAV and compare patients with and without recurrence to identify potential predictors of recurrence.This retrospective medical record review study included children diagnosed with IgAV between 2015 and 2025 according to the EULAR/PRINTO/PRES classification criteria. Patients with incomplete data, follow-up duration < 6 months, or alternative diagnoses were excluded. Clinical manifestations, laboratory findings, treatment characteristics, and recurrence patterns were compared between patients with and without recurrence. Cox proportional hazards regression analysis was performed to identify independent predictors of recurrence.A total of 417 children with IgAV were included, of whom 50 (12.0%) developed recurrence. Recurrent disease was characterized by more severe cutaneous involvement, with significantly higher frequencies of widespread or bullous cutaneous manifestations, as well as higher frequencies of arthritis and microscopic hematuria at presentation. Preceding infection was significantly more common among recurrent patients and independently increased relapse risk (HR: 2.33, 95% CI: 1.20–4.51). Microscopic hematuria (HR: 3.00, 95% CI: 1.62–5.57), widespread/bullous cutaneous involvement (HR: 2.65, 95% CI: 1.47–4.80), and joint involvement (HR: 2.98, 95% CI: 1.55–5.73) also emerged as independent predictors of recurrence. In addition, lower monocyte counts were independently associated with relapse risk (HR: 0.82, 95% CI: 0.71–0.95). Colchicine use was significantly more frequent among recurrent patients, likely reflecting therapeutic preferences related to recurrent cutaneous involvement. Conclusions: Preceding infection, microscopic hematuria, extensive or bullous skin involvement, joint involvement, and lower monocyte counts may help identify patients at higher risk of recurrence. (Table presented.)